Ons laatste nieuws
Dutch Backyard Chickens Deliver Shocking PFAS Levels Through Contaminated Worms
Bilthoven, Monday, 16 March 2026.
A groundbreaking RIVM study reveals that hobby chickens consuming worms from Dutch soil are laying eggs with dangerously high PFAS concentrations—potentially delivering a year’s worth of chemical exposure in just three eggs. Published March 16, 2026, the research confirms that earthworms act as toxic conduits, concentrating these ‘forever chemicals’ from contaminated soil directly into backyard egg production. The findings validate health warnings issued in April 2025 advising against consuming hobby chicken eggs nationwide. Commercial supermarket eggs remain safe due to controlled farming conditions that limit worm access, but backyard enthusiasts face a stark choice between natural chicken-keeping practices and food safety.
Laatste nieuws in green
Dutch City Targets Climate Neutrality Decade Ahead of National Goal
Dordrecht, Sunday, 15 March 2026.
Dordrecht has slashed CO2 emissions by 46% since 2019 and aims for climate neutrality by 2040, beating Netherlands’ 2050 target by ten years. The city connects over 8,000 homes to renewable heating networks, installed solar panels on 13,000 rooftops producing 113 gigawatt hours, and plans 400 shared cars. With current emissions at 600,000 tons annually, alderman Tanja de Jonge emphasizes cities can drive meaningful change in daily life through housing, mobility, and energy choices.
Laatste nieuws in community
Academic Researcher Reveals Why Doubt Can Be a Strength in Technical Innovation
Eindhoven, Sunday, 15 March 2026.
A postdoc at TU Eindhoven is challenging academia’s confidence culture by advocating for psychological safety in research environments. Jennifer van den Berg argues that expressing uncertainty actually drives breakthrough innovation, noting the crucial tension between research requiring doubt while people are expected to project confidence. Her insights, shared during TU/e’s recent Wellbeing Week, emphasize that even expert researchers can be in exploratory phases without diminishing their credibility or visibility in their fields.
Laatste nieuws in data
Netherlands Emerges as Europe's Digital Infrastructure Powerhouse
Amsterdam, Monday, 16 March 2026.
The Netherlands has positioned itself as a global leader in digital transformation, with digital trade accounting for over 75% of its GDP. The country’s strategic use of its ‘NL’ digital identity framework underpins everything from 5G networks to emergency services, while innovative projects like AI-powered archive digitization and cybersecurity innovation funds demonstrate practical applications. However, challenges remain, as Dutch hospitals find AI technology delivering less than expected returns despite increased adoption.
Laatste nieuws in semicon
ASML Cuts 1,700 Jobs Despite Record Profits to Fight Corporate Bloat
Veldhoven, Saturday, 14 March 2026.
Dutch semiconductor giant ASML eliminated 1,700 positions in January 2026 after earning €10 billion in profits, with Technical Director Marco Pieters declaring the company had become ‘sluggish’ and wasteful. The restructuring affects 4,500 managers who must reapply for positions as ASML streamlines its 16,000-person engineering division. Pieters admits the company lost efficiency through excessive meetings and bureaucratic processes during rapid growth, contradicting typical corporate logic of hiring during boom periods.
Laatste nieuws in bio
All-Female Biotech Startup Defies Investment Odds with Breakthrough Arthritis Drug
Netherlands, Sunday, 15 March 2026.
Dutch biotech company Amplio Pharma secured over €1.3 million in funding despite facing a stark reality: less than 3% of European venture capital reaches female-founded companies. The all-female founding team developed NovoBioJect, an innovative treatment that makes existing rheumatoid arthritis medication more effective at lower doses by keeping it in cells longer. Founded in Sweden in 2020, the company relocated to the Netherlands in 2023 after finding greater support for their healthcare vision. Their breakthrough technology combines methotrexate with novobiocin, potentially reducing side effects like nausea and fatigue while cutting healthcare costs by delaying expensive alternative treatments.
